Literature DB >> 26299985

Systemic lupus erythematosus and atherosclerosis: Review of the literature.

Marianne Frieri1, Heather Stampfl2.   

Abstract

The purpose of this manuscript is to extensively review the literature related to systemic lupus erythematosus and atherosclerosis. The conclusion of this review has covered accelerated atherosclerosis in systemic lupus erythematosus, the role of complement, interferon in premature atherosclerosis, inflammatory mediators such as cytokines, leukocytes, innate and adaptive immunity, hydrolytic enzymes, reactive oxygen species, vascular endothelial growth factor, toll receptors in lupus nephritis, several specific anti-inflammatory pharmacological therapies, and potential prevention strategies for atherothrombotic events, interferons and the inflammasome. It is important for allergist-immunologists, rheumatologists both in academic institutions and in practice to understand this important disorder.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Complement; Cytokines; Innate; Interferon

Mesh:

Substances:

Year:  2015        PMID: 26299985     DOI: 10.1016/j.autrev.2015.08.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  14 in total

Review 1.  Microbes, Immunity, and Behavior: Psychoneuroimmunology Meets the Microbiome.

Authors:  Timothy G Dinan; John F Cryan
Journal:  Neuropsychopharmacology       Date:  2016-06-20       Impact factor: 7.853

2.  Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study.

Authors:  Abdulla Watad; Arsalan Abu Much; Danielle Bracco; Naim Mahroum; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 3.  Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.

Authors:  Savino Sciascia; Massimo Radin; Jinoos Yazdany; Maria Tektonidou; Irene Cecchi; Dario Roccatello; Maria Dall'Era
Journal:  Rheumatol Int       Date:  2017-03-03       Impact factor: 2.631

Review 4.  Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.

Authors:  Alexandre T J Maria; Marie Maumus; Alain Le Quellec; Christian Jorgensen; Danièle Noël; Philippe Guilpain
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

5.  Categorisation of foot complaints in systemic lupus erythematosus (SLE) from a New Zealand cohort.

Authors:  Simon J Otter; Maheswaran Rohan; Kevin A Davies; Sunil Kumar; Peter Gow; Nicola Dalbeth; Michael Corkill; Sam Panthakalam; Keith Rome
Journal:  J Foot Ankle Res       Date:  2017-07-26       Impact factor: 2.303

Review 6.  IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases.

Authors:  Raghu Patil Junjappa; Prakash Patil; Kashi Raj Bhattarai; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 7.561

7.  Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus.

Authors:  Mónica Vázquez-Del Mercado; Felipe de J Perez-Vazquez; Eduardo Gomez-Bañuelos; Efrain Chavarria-Avila; Arcelia Llamas-García; Karla I Arrona-Rios; Gustavo Ignacio Diaz-Rubio; Sergio Durán-Barragán; Rosa E Navarro-Hernández; Bethel P Jordán-Estrada; Natalia Prado-Bachega; Miguel A A Gonzalez-Beltran; Carlos Ramos-Becerra; Fernando Grover-Paez; David Cardona-Müller; Ernesto G Cardona-Muñoz
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

Review 8.  Roles of Oral Infections in the Pathomechanism of Atherosclerosis.

Authors:  Ghazal Aarabi; Guido Heydecke; Udo Seedorf
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

Review 9.  The Role of Neutrophils and Neutrophil Extracellular Traps in Vascular Damage in Systemic Lupus Erythematosus.

Authors:  Liam J O'Neil; Mariana J Kaplan; Carmelo Carmona-Rivera
Journal:  J Clin Med       Date:  2019-08-28       Impact factor: 4.241

10.  Elevation of serum proprotein convertase subtilisin/kexin type 9 (PCSK9) concentrations and its possible atherogenic role in patients with systemic lupus erythematosus.

Authors:  Chenglong Fang; Tingting Luo; Ling Lin
Journal:  Ann Transl Med       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.